Corvus Pharmaceuticals (CRVS) Stock Highlights

4.99 | -1.96%

2024-12-21 05:15:09

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The companys lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.

Statistics

Range Today

4.73 5.34

Volume Today 2.59M

Range 1 Year

1.3 10

Volume 1 Year 116.8M

Range 3 Year

0.61 10

Volume 3 Year 295.94M

Range 10 Year

0.61 22.137

Volume 10 Year 1.24B

Highlights

Market Capitalization 591.11M (small)

Floating Shares 38M

Current Price 4.99

Price To Earnings -18.93

Price To Book 11.54

Earnings Per Share -0.46

Payout Ratio 0%

Performance

Latest -1.96%

1 Month -40.17%

3 Months -11.99%

6 Months +165.43%

1 Year +202.42%

3 Years +87.59%

5 Years +19.95%

10 Years -66.73%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.